Agilent Technologies, Inc.
Composition for stabilization of antibody formulations containing PerCP

Abstract:

The present disclosure is directed to formulations and methods that can be used for flow cytometry analysis. The present formulations and methods involve the use of PerCP to stabilize fluorochromes used in flow cytometry, allowing for use and storage of formulations at elevated temperatures and/or over long periods of time.